Hassan Yousefi, PhD

Title(s)Postdoctoral Scholar, Biochemistry and Biophysics
SchoolSchool of Medicine
Address600-16th Street
Phone415-230-5189
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ceritinib is a novel triple negative breast cancer therapeutic agent. Mol Cancer. 2022 06 29; 21(1):138. Dong S, Yousefi H, Savage IV, Okpechi SC, Wright MK, Matossian MD, Collins-Burow BM, Burow ME, Alahari SK. PMID: 35768871; PMCID: PMC9241294.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    2. Expression of Novel Kinase MAP3K19 in Various Cancers and Survival Correlations. Front Biosci (Landmark Ed). 2022 06 17; 27(6):196. Nguyen K, Yousefi H, Cheng T, Magrath J, Hartono AB, Alzoubi M, Hebert K, Brock CK, Wright MK, Byrne CE, Rivera A, Okpechi SC, Matossian MD, Wathieu H, Elliott S, Mondrinos MJ, Lee SB, Collins-Burow BM, Alahari SK, Drewry DH, Burow ME. PMID: 35748272.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Mechanisms of miR-3189-3p-mediated inhibition of c-MYC translation in triple negative breast cancer. Cancer Cell Int. 2022 May 31; 22(1):204. Vittori C, Jeansonne D, Yousefi H, Faia C, Lin Z, Reiss K, Peruzzi F. PMID: 35642054; PMCID: PMC9158314.
      View in: PubMed   Mentions:
    4. Hippo signaling pathway: A comprehensive gene expression profile analysis in breast cancer. Biomed Pharmacother. 2022 Jul; 151:113144. Yousefi H, Delavar MR, Piroozian F, Baghi M, Nguyen K, Cheng T, Vittori C, Worthylake D, Alahari SK. PMID: 35623167.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    5. NR4A Family Genes: A Review of Comprehensive Prognostic and Gene Expression Profile Analysis in Breast Cancer. Front Oncol. 2022; 12:777824. Yousefi H, Fong J, Alahari SK. PMID: 35547878; PMCID: PMC9082356.
      View in: PubMed   Mentions:
    6. Nischarin Deletion Reduces Oxidative Metabolism and Overall ATP: A Study Using a Novel NISCHΔ5-6 Knockout Mouse Model. Int J Mol Sci. 2022 Jan 25; 23(3). Nguyen TH, Yousefi H, Okpechi SC, Lauterboeck L, Dong S, Yang Q, Alahari SK. PMID: 35163298; PMCID: PMC8835720.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    7. Role of Nischarin in the pathology of diseases: a special emphasis on breast cancer. Oncogene. 2022 02; 41(8):1079-1086. Okpechi SC, Yousefi H, Nguyen K, Cheng T, Alahari NV, Collins-Burow B, Burow ME, Alahari SK. PMID: 35064214.
      View in: PubMed   Mentions:    Fields:    
    8. Cancer exosomes and natural killer cells dysfunction: biological roles, clinical significance and implications for immunotherapy. Mol Cancer. 2022 01 14; 21(1):15. Hosseini R, Sarvnaz H, Arabpour M, Ramshe SM, Asef-Kabiri L, Yousefi H, Akbari ME, Eskandari N. PMID: 35031075; PMCID: PMC8759167.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    9. Blockade of Nuclear Factor-Κb (NF-Κb) Pathway Using Bay 11-7082 Enhances Arsenic Trioxide-Induced Antiproliferative Activity in U87 Glioblastoma Cells. Rep Biochem Mol Biol. 2022 Jan; 10(4):602-613. Nasrollahzadeh A, Momeny M, Bashash D, Yousefi H, Mousavi SA, Ghaffari SH. PMID: 35291620; PMCID: PMC8903363.
      View in: PubMed   Mentions:
    10. Cediranib, a pan-inhibitor of vascular endothelial growth factor receptors, inhibits proliferation and enhances therapeutic sensitivity in glioblastoma cells. Life Sci. 2021 Dec 15; 287:120100. Momeny M, Shamsaiegahkani S, Kashani B, Hamzehlou S, Esmaeili F, Yousefi H, Irani S, Mousavi SA, Ghaffari SH. PMID: 34715143.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    11. The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells. Mol Cancer. 2021 06 02; 20(1):83. Hosseini R, Asef-Kabiri L, Yousefi H, Sarvnaz H, Salehi M, Akbari ME, Eskandari N. PMID: 34078376; PMCID: PMC8170799.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    12. Evaluation of liver kinase B1 downstream signaling expression in various breast cancers and relapse free survival after systemic chemotherapy treatment. Oncotarget. 2021 May 25; 12(11):1110-1115. Nguyen K, Rivera A, Alzoubi M, Wathieu H, Dong S, Yousefi H, Matossian M, Alahari S, Drewry D, Burow M, Collins-Burow B. PMID: 34084284; PMCID: PMC8169068.
      View in: PubMed   Mentions: 1     Fields:    
    13. Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer. Cancer Lett. 2021 06 01; 507:112-123. Mohajan S, Jaiswal PK, Vatanmakarian M, Yousefi H, Sankaralingam S, Alahari SK, Koul S, Koul HK. PMID: 33737002.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    14. Immune and metabolic checkpoints blockade: Dual wielding against tumors. Int Immunopharmacol. 2021 May; 94:107461. Kazemi MH, Najafi A, Karami J, Ghazizadeh F, Yousefi H, Falak R, Safari E. PMID: 33592403.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    15. The oncogenic and tumor suppressive roles of RNA-binding proteins in human cancers. J Cell Physiol. 2021 09; 236(9):6200-6224. Bitaraf A, Razmara E, Bakhshinejad B, Yousefi H, Vatanmakanian M, Garshasbi M, Cho WC, Babashah S. PMID: 33559213.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    16. Graves' disease: introducing new genetic and epigenetic contributors. J Mol Endocrinol. 2021 02; 66(2):R33-R55. Razmara E, Salehi M, Aslani S, Bitaraf A, Yousefi H, Colón JR, Mahmoudi M. PMID: 33295879.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCells
    17. Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance. Oncogene. 2021 02; 40(6):1043-1063. Yousefi H, Vatanmakanian M, Mahdiannasser M, Mashouri L, Alahari NV, Monjezi MR, Ilbeigi S, Alahari SK. PMID: 33420366.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    18. Opposite trends of GAS6 and GAS6-AS expressions in breast cancer tissues. Exp Mol Pathol. 2021 02; 118:104600. Lavasani A, Hussen BM, Taheri F, Sattari A, Yousefi H, Omrani MD, Nazer N, Ghafouri-Fard S, Taheri M. PMID: 33359886.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Effects of different autophagy inhibitors on sensitizing KG-1 and HL-60 leukemia cells to chemotherapy. IUBMB Life. 2021 01; 73(1):130-145. Haghi A, Salemi M, Fakhimahmadi A, Mohammadi Kian M, Yousefi H, Rahmati M, Mohammadi S, Ghavamzadeh A, Moosavi MA, Nikbakht M. PMID: 33205598.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    20. Docosahexaenoic acid reverses the promoting effects of breast tumor cell-derived exosomes on endothelial cell migration and angiogenesis. Life Sci. 2021 Jan 01; 264:118719. Ghaffari-Makhmalbaf P, Sayyad M, Pakravan K, Razmara E, Bitaraf A, Bakhshinejad B, Goudarzi P, Yousefi H, Pournaghshband M, Nemati F, Fahimi H, Rohollah F, Hasanzad M, Hashemi M, Mousavi SH, Babashah S. PMID: 33159957.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    21. Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action. Biochem Pharmacol. 2021 01; 183:114296. Yousefi H, Mashouri L, Okpechi SC, Alahari N, Alahari SK. PMID: 33191206; PMCID: PMC7581400.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    22. SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach. Biomed Pharmacother. 2020 Oct; 130:110548. Yousefi H, Poursheikhani A, Bahmanpour Z, Vatanmakanian M, Taheri M, Mashouri L, Alahari SK. PMID: 33475497; PMCID: PMC7386606.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    23. DICER-AS1 lncRNA: A putative culprit in the pathogenesis of gastric cancer. Exp Mol Pathol. 2020 10; 116:104490. Afrough H, Ghafouri-Fard S, Yousefi H, Pakzad P, Kholghi Oskooei V, Taheri M. PMID: 32663487.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    24. Cediranib, an inhibitor of vascular endothelial growth factor receptor kinases, inhibits proliferation and invasion of prostate adenocarcinoma cells. Eur J Pharmacol. 2020 Sep 05; 882:173298. Momeny M, Sankanian G, Hamzehlou S, Yousefi H, Esmaeili F, Alishahi Z, Karimi B, Zandi Z, Shamsaiegahkani S, Sabourinejad Z, Kashani B, Nasrollahzadeh A, Mousavipak SH, Mousavi SA, Ghaffari SH. PMID: 32593665.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    25. Non-coding RNAs underlying chemoresistance in gastric cancer. Cell Oncol (Dordr). 2020 Dec; 43(6):961-988. Poursheikhani A, Bahmanpour Z, Razmara E, Mashouri L, Taheri M, Morshedi Rad D, Yousefi H, Bitaraf A, Babashah S. PMID: 32495294.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    26. Vitamin D receptor (VDR) gene polymorphism and risk of rheumatoid arthritis (RA): systematic review and meta-analysis. Clin Rheumatol. 2020 Dec; 39(12):3555-3569. Bagheri-Hosseinabadi Z, Imani D, Yousefi H, Abbasifard M. PMID: 32445089.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    27. EGFR Blockade Reverses Cisplatin Resistance in Human Epithelial Ovarian Cancer Cells. Iran Biomed J. 2020 11; 24(6):370-8. Poursheikhani A, Yousefi H, Tavakoli-Bazzaz J, Seyed H G. PMID: 32660222; PMCID: PMC7601546.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    28. MTHFR gene polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis based on 16 studies. Clin Rheumatol. 2020 Aug; 39(8):2267-2279. Bagheri-Hosseinabadi Z, Imani D, Yousefi H, Abbasifard M. PMID: 32170488.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    29. Clinicopathological Significance of Long Non-Coding RNA GHET1 in Human Cancers: A Meta-Analysis. Curr Pharm Biotechnol. 2020; 21(14):1422-1432. Poursheikhani A, Nokhandani N, Yousefi H, Rad DM, Sahebkar A. PMID: 32720600.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    30. Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance. Oncogene. 2020 01; 39(5):953-974. Yousefi H, Maheronnaghsh M, Molaei F, Mashouri L, Reza Aref A, Momeny M, Alahari SK. PMID: 31601996.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    31. Anti-tumor activity of neratinib, a pan-HER inhibitor, in gastric adenocarcinoma cells. Eur J Pharmacol. 2019 Nov 15; 863:172705. Hamzehlou S, Momeny M, Zandi Z, Kashani B, Yousefi H, Dehpour AR, Tavakkoly-Bazzaz J, Ghaffari SH. PMID: 31574259.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    32. Non-Coding RNAs in Cartilage Development: An Updated Review. Int J Mol Sci. 2019 Sep 11; 20(18). Razmara E, Bitaraf A, Yousefi H, Nguyen TH, Garshasbi M, Cho WC, Babashah S. PMID: 31514268; PMCID: PMC6769748.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCells
    33. Generation of Induced Pluripotent Cancer Cells from Glioblastoma Multiform Cell Lines. Cell Reprogram. 2019 10; 21(5):238-248. Vatanmakanian M, Yousefi H, Mashouri L, Aref AR, Khamisipour G, Bitaraf A, Alizadeh S. PMID: 31369321.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    34. The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells. Cell Oncol (Dordr). 2019 Aug; 42(4):491-504. Momeny M, Esmaeili F, Hamzehlou S, Yousefi H, Javadikooshesh S, Vahdatirad V, Alishahi Z, Mousavipak SH, Bashash D, Dehpour AR, Tavangar SM, Tavakkoly-Bazzaz J, Haddad P, Kordbacheh F, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. PMID: 31025257.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    35. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer. 2019 04 02; 18(1):75. Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F, Alahari SK. PMID: 30940145; PMCID: PMC6444571.
      View in: PubMed   Mentions: 275     Fields:    Translation:HumansCells
    36. IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer. Tumori. 2019 Feb; 105(1):84-91. Yousefi H, Momeny M, Ghaffari SH, Parsanejad N, Poursheikhani A, Javadikooshesh S, Zarrinrad G, Esmaeili F, Alishahi Z, Sabourinejad Z, Sankanian G, Shamsaiegahkani S, Bashash D, Shahsavani N, Tavakkoly-Bazzaz J, Alimoghaddam K, Ghavamzadeh A. PMID: 30021477.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    37. Blockade of nuclear factor-κB (NF-κB) pathway inhibits growth and induces apoptosis in chemoresistant ovarian carcinoma cells. Int J Biochem Cell Biol. 2018 06; 99:1-9. Momeny M, Yousefi H, Eyvani H, Moghaddaskho F, Salehi A, Esmaeili F, Alishahi Z, Barghi F, Vaezijoze S, Shamsaiegahkani S, Zarrinrad G, Sankanian G, Sabourinejad Z, Hamzehlou S, Bashash D, Aboutorabi ES, Ghaffari P, Dehpour AR, Tavangar SM, Tavakkoly-Bazzaz J, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. PMID: 29567488.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    38. In silico Homology Modeling and Epitope Prediction of NadA as a Potential Vaccine Candidate in Neisseria meningitidis. Int J Mol Cell Med. 2018; 7(1):53-68. Shahsavani N, Sheikhha MH, Yousefi H, Sefid F. PMID: 30234073; PMCID: PMC6134420.
      View in: PubMed   Mentions: 6  
    39. Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells. Sci Rep. 2017 06 23; 7(1):4204. Momeny M, Zarrinrad G, Moghaddaskho F, Poursheikhani A, Sankanian G, Zaghal A, Mirshahvaladi S, Esmaeili F, Eyvani H, Barghi F, Sabourinejad Z, Alishahi Z, Yousefi H, Ghasemi R, Dardaei L, Bashash D, Chahardouli B, Dehpour AR, Tavakkoly-Bazzaz J, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. PMID: 28646172; PMCID: PMC5482808.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    40. Anti-tumour activity of tivozanib, a pan-inhibitor of VEGF receptors, in therapy-resistant ovarian carcinoma cells. Sci Rep. 2017 04 06; 7:45954. Momeny M, Sabourinejad Z, Zarrinrad G, Moghaddaskho F, Eyvani H, Yousefi H, Mirshahvaladi S, Poursani EM, Barghi F, Poursheikhani A, Dardaei L, Bashash D, Ghazi-Khansari M, Tavangar SM, Dehpour AR, Yaghmaie M, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. PMID: 28383032; PMCID: PMC5382685.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    41. Blockade of vascular endothelial growth factor receptors by tivozanib has potential anti-tumour effects on human glioblastoma cells. Sci Rep. 2017 03 13; 7:44075. Momeny M, Moghaddaskho F, Gortany NK, Yousefi H, Sabourinejad Z, Zarrinrad G, Mirshahvaladi S, Eyvani H, Barghi F, Ahmadinia L, Ghazi-Khansari M, Dehpour AR, Amanpour S, Tavangar SM, Dardaei L, Emami AH, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. PMID: 28287096; PMCID: PMC5347040.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    Hassan's Networks
    Concepts (183)
    Derived automatically from this person's publications.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _